导管原位癌患者的生活质量问题
Quality-of-life issues in patients with ductal carcinoma in situ.
作者信息
Ganz Patricia A
机构信息
Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Dr South, Rm A2-125 CHS, Los Angeles, CA 90095-6900, USA.
出版信息
J Natl Cancer Inst Monogr. 2010;2010(41):218-22. doi: 10.1093/jncimonographs/lgq029.
Abstract
Ductal carcinoma in situ (DCIS) as we know it today is a clinical entity that is primarily discovered through the finding of microscopic calcifications on a screening mammogram. Asymptomatic women who are found to have DCIS receive treatments that are similar to women with invasive breast cancer and experience substantial psychological distress in spite of having an excellent prognosis and normal life expectancy. More research is needed to determine the best way to communicate with women about this condition and to match the extent of treatment with the risk of serious future disease. Clinical and research efforts should focus on reducing the anxiety and psychological distress associated with the diagnosis of DCIS.
摘要
我们如今所熟知的导管原位癌（DCIS）是一种临床实体，主要通过筛查乳房X光片上发现的微小钙化来确诊。被发现患有DCIS的无症状女性接受的治疗与浸润性乳腺癌女性相似，尽管预后良好且预期寿命正常，但她们仍会经历严重的心理困扰。需要更多研究来确定与女性沟通这种疾病的最佳方式，并使治疗程度与未来患严重疾病的风险相匹配。临床和研究工作应专注于减轻与DCIS诊断相关的焦虑和心理困扰。
相似文献
1
Quality-of-life issues in patients with ductal carcinoma in situ.
J Natl Cancer Inst Monogr. 2010;2010(41):218-22. doi: 10.1093/jncimonographs/lgq029.
2
What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions?
Breast Cancer. 2017 Sep;24(5):720-729. doi: 10.1007/s12282-017-0765-0. Epub 2017 Feb 28.
3
Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer.
Breast Cancer Res Treat. 2010 Apr;120(3):685-91. doi: 10.1007/s10549-009-0477-z. Epub 2009 Aug 4.
4
Optimal management of ductal carcinoma in situ of the breast.
Surg Oncol. 2003 Dec;12(4):221-40. doi: 10.1016/S0960-7404(03)00031-8.
5
Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients.
Breast Cancer Res Treat. 2018 Jan;167(1):205-213. doi: 10.1007/s10549-017-4495-y. Epub 2017 Sep 11.
6
The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.
J Natl Cancer Inst Monogr. 2010;2010(41):130-3. doi: 10.1093/jncimonographs/lgq022.
7
Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12.
8
The challenge of being diagnosed and treated for ductal carcinoma in situ (DCIS).
Eur J Oncol Nurs. 2008 Apr;12(2):103-11. doi: 10.1016/j.ejon.2007.09.007. Epub 2007 Nov 26.
9
The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast.
J Natl Cancer Inst Monogr. 2010;2010(41):187-92. doi: 10.1093/jncimonographs/lgq020.
10
Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Cancer Treat Rev. 2000 Apr;26(2):103-25. doi: 10.1053/ctrv.1999.0149.
引用本文的文献
1
Comparative Analyses of Van Nuys Prognostic Index and NCCN Guidelines in Ductal Carcinoma Treatment in a Brazilian Hospital.
Life (Basel). 2025 Mar 9;15(3):432. doi: 10.3390/life15030432.
2
Managing Symptom Distress: Key Factors for Patients on Adjuvant Endocrine Therapy for Breast Cancer.
J Pain Symptom Manage. 2024 Jan;67(1):88-97. doi: 10.1016/j.jpainsymman.2023.10.001. Epub 2023 Oct 9.
3
Non-systemic Approaches for Ductal Carcinoma In Situ: Exploring the Potential of Ultra-flexible Combisomes as a Novel Drug Delivery Strategy-a Review.
AAPS PharmSciTech. 2023 May 12;24(5):119. doi: 10.1208/s12249-023-02574-z.
4
Cancer overdiagnosis: a challenge in the era of screening.
J Natl Cancer Cent. 2022 Dec;2(4):235-242. doi: 10.1016/j.jncc.2022.08.005. Epub 2022 Aug 21.
5
Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review.
Cancers (Basel). 2022 Jul 2;14(13):3259. doi: 10.3390/cancers14133259.
6
Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial.
J Natl Cancer Inst. 2021 Nov 2;113(11):1523-1530. doi: 10.1093/jnci/djab083.
7
Ductal carcinoma in situ: to treat or not to treat, that is the question.
Br J Cancer. 2019 Aug;121(4):285-292. doi: 10.1038/s41416-019-0478-6. Epub 2019 Jul 9.
8
Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect.
Breast Cancer Res Treat. 2018 Sep;171(2):435-442. doi: 10.1007/s10549-018-4824-9. Epub 2018 May 28.
9
The association between post-diagnosis health behaviors and long-term quality of life in survivors of ductal carcinoma in situ: a population-based longitudinal cohort study.
Qual Life Res. 2018 May;27(5):1237-1247. doi: 10.1007/s11136-018-1807-6. Epub 2018 Feb 7.
10
Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.
J Clin Oncol. 2016 Apr 20;34(12):1323-9. doi: 10.1200/JCO.2015.62.7281. Epub 2016 Feb 16.
本文引用的文献
1
Screening for breast cancer: an update for the U.S. Preventive Services Task Force.
Ann Intern Med. 2009 Nov 17;151(10):727-37, W237-42. doi: 10.7326/0003-4819-151-10-200911170-00009.
2
Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer.
Breast Cancer Res Treat. 2010 Apr;120(3):685-91. doi: 10.1007/s10549-009-0477-z. Epub 2009 Aug 4.
3
Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery.
J Clin Oncol. 2009 Jul 1;27(19):3211-6. doi: 10.1200/JCO.2008.18.5876. Epub 2009 May 11.
4
Breast cancer classification: time for a change.
J Clin Oncol. 2009 May 20;27(15):2427-8. doi: 10.1200/JCO.2008.21.2647. Epub 2009 Apr 20.
5
The natural history of invasive breast cancers detected by screening mammography.
Arch Intern Med. 2008 Nov 24;168(21):2311-6. doi: 10.1001/archinte.168.21.2311.
6
Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ.
Clin Breast Cancer. 2008 Jun;8(3):275-80. doi: 10.3816/CBC.2008.n.032.
7
Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.
Breast Cancer Res. 2008;10(2):R26. doi: 10.1186/bcr1983. Epub 2008 Mar 27.
8
Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12.
9
Symptom experience and quality of life of women following breast cancer treatment.
J Womens Health (Larchmt). 2007 Nov;16(9):1348-61. doi: 10.1089/jwh.2006.0255.
10
A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ.
Eur J Cancer. 2007 Feb;43(3):549-56. doi: 10.1016/j.ejca.2006.10.010. Epub 2006 Nov 30.
Zotero 插件